Notably, our study provides evidence that inducing and/or maintaining PRL/PRLR signaling is critical in restricting and suppressing breast tumorigenesis and promoting its differentiation function may hold therapeutic value in breast cancer. This evidence concerns the gene PRLR and breast carcinoma.